-DOCSTART- -X- O
Animal -X- _ O
experiments -X- _ O
are -X- _ O
widely -X- _ O
used -X- _ O
in -X- _ O
preclinical -X- _ O
medical -X- _ O
research -X- _ O
with -X- _ O
the -X- _ O
goal -X- _ O
of -X- _ O
disease -X- _ O
modeling -X- _ O
and -X- _ O
exploration -X- _ O
of -X- _ O
novel -X- _ O
therapeutic -X- _ O
approaches. -X- _ O
In -X- _ O
the -X- _ O
context -X- _ O
of -X- _ O
sepsis -X- _ O
and -X- _ O
septic -X- _ B-Intervention
shock -X- _ I-Intervention
, -X- _ O
the -X- _ O
translation -X- _ O
into -X- _ O
clinical -X- _ O
practice -X- _ O
has -X- _ O
been -X- _ O
disappointing. -X- _ O
Classical -X- _ O
animal -X- _ B-Patient
models -X- _ I-Patient
of -X- _ O
septic -X- _ B-Intervention
shock -X- _ I-Intervention
usually -X- _ O
involve -X- _ O
one-sex-one-age -X- _ O
animal -X- _ B-Patient
models -X- _ I-Patient
, -X- _ O
mostly -X- _ O
in -X- _ O
mice -X- _ B-Patient
or -X- _ I-Patient
rats -X- _ I-Patient
, -X- _ O
contrasting -X- _ O
with -X- _ O
the -X- _ O
heterogeneous -X- _ O
population -X- _ O
of -X- _ O
septic -X- _ B-Comparison
shock -X- _ I-Comparison
patients. -X- _ I-Comparison
Many -X- _ B-Outcome
other -X- _ I-Outcome
factors -X- _ I-Outcome
limit -X- _ I-Outcome
the -X- _ I-Outcome
reliability -X- _ I-Outcome
of -X- _ I-Outcome
preclinical -X- _ I-Outcome
models -X- _ I-Outcome
and -X- _ I-Outcome
may -X- _ I-Outcome
contribute -X- _ I-Outcome
to -X- _ I-Outcome
preclinical -X- _ I-Outcome
research -X- _ I-Outcome
failure -X- _ I-Outcome
in -X- _ I-Outcome
critical -X- _ I-Outcome
care -X- _ I-Outcome
, -X- _ I-Outcome
including -X- _ I-Outcome
the -X- _ I-Outcome
host -X- _ I-Outcome
specificity -X- _ I-Outcome
of -X- _ I-Outcome
several -X- _ I-Outcome
pathogens -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
fact -X- _ I-Outcome
that -X- _ I-Outcome
laboratory -X- _ I-Outcome
animals -X- _ I-Outcome
are -X- _ I-Outcome
raised -X- _ I-Outcome
in -X- _ I-Outcome
pathogen-free -X- _ I-Outcome
facilities -X- _ I-Outcome
and -X- _ I-Outcome
that -X- _ I-Outcome
organ -X- _ I-Outcome
support -X- _ I-Outcome
techniques -X- _ I-Outcome
are -X- _ I-Outcome
either -X- _ I-Outcome
absent -X- _ I-Outcome
or -X- _ I-Outcome
minimal. -X- _ I-Outcome
Advanced -X- _ O
animal -X- _ B-Patient
models -X- _ I-Patient
have -X- _ O
been -X- _ O
developed -X- _ O
with -X- _ O
the -X- _ O
aim -X- _ O
of -X- _ O
improving -X- _ O
the -X- _ O
clinical -X- _ O
translatability -X- _ O
of -X- _ O
experimental -X- _ O
findings. -X- _ O
So-called -X- _ O
animal -X- _ O
ICUs -X- _ O
refer -X- _ O
to -X- _ O
the -X- _ O
preclinical -X- _ O
investigation -X- _ O
of -X- _ O
adult -X- _ O
or -X- _ O
even -X- _ O
aged -X- _ O
animals -X- _ O
of -X- _ O
either -X- _ O
sex -X- _ O
, -X- _ O
using—in -X- _ O
case -X- _ O
of -X- _ O
rats -X- _ O
and -X- _ O
mice—miniaturized -X- _ O
equipment -X- _ O
allowing -X- _ O
for -X- _ O
reproducing -X- _ O
an -X- _ O
ICU -X- _ O
environment -X- _ O
at -X- _ O
a -X- _ O
small -X- _ O
animal -X- _ O
scale -X- _ O
and -X- _ O
integrating -X- _ O
chronic -X- _ O
comorbidities -X- _ O
to -X- _ O
more -X- _ O
closely -X- _ O
reflect -X- _ O
the -X- _ O
clinical -X- _ O
conditions -X- _ O
studied. -X- _ O
Strength -X- _ O
and -X- _ O
limitations -X- _ O
of -X- _ O
preclinical -X- _ O
animal -X- _ B-Patient
models -X- _ I-Patient
designed -X- _ O
to -X- _ O
decipher -X- _ O
the -X- _ O
mechanisms -X- _ O
involved -X- _ O
in -X- _ O
septic -X- _ O
cardiomyopathy -X- _ O
are -X- _ O
discussed. -X- _ O
This -X- _ O
article -X- _ O
reviews -X- _ O
the -X- _ O
current -X- _ O
status -X- _ O
and -X- _ O
the -X- _ O
challenges -X- _ O
of -X- _ O
setting -X- _ O
up -X- _ O
an -X- _ O
animal -X- _ O
ICU -X- _ O
. -X- _ O

